Patent applications published 23 February 2011
Selected patent applications from the weekly European Patents Bulletin
- Improved quenching methods for red blood cell pathogen inactivation
Cerus 2285210*
- Novel pyriproxyfen compsns
Valent 2285212*
- Microemulsion germicidal compsn
Ethicon 2285213*
- Rasagiline soft gelatin capsules
Teva Pharmaceutical Industries 2285214*
- Novel compounds, pharmaceutical compsns containing same, and methods for use of same
Fasgen, The Johns Hopkins University 2285215*
- HIV protease inhibitor and cytochrome P450 inhibitor combinations
Sequoia Pharmaceuticals 2285216*
- Compounds for improving learning and memory
Amnestix 2285217*
- Dietary compsns and methods for protection against chemotherapy, radiotherapy, oxidative stress and ageing
University of Southern California 2285218*
- Controlled release formulations of alprazolam
Supernus Pharmaceuticals 2285219*
- Sweet containing algae for the prevention of oro-dental infections
Roquette Freres 2285344*
- Pulmonary delivery of a fluoroquinolone
Novartis 2285345*
- Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics
Donnenfled, Eric 2285346*
- Compsns and methods for treating digestive disorders
Revalesio 2285347*
- Opioid compsn for treating skin lesions
Euro-Celtique 2285348*
- Perfluorocarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
Soluventis 2285349*
- Methods for the preparation of targeting agent functionalised diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
Bind Biosciences 2285350*
- Oral pharmaceutical compsns in a solid dispersion comprising preferably posaconazole and HPMCAS
Schering 2285351*
- Atrovastatin compsns
Dr Reddy’s Laboratories Ltd; Dr Reddy’s Laboratories Inc 2285352*
- Modified release formulations of HMG CoA reductase inhibitors
Lupin 2285353*
- Process for preparing a low drug load tablet
Atacama Labs 2285354*
- Process for preparing a high drug load tablet
Atacama Labs 2285355*
- Process for preparing a tablet comprising metformin
Atacama Labs 2285356*
- Pharmaceutical compsns comprising brivaracetam
UCB Pharma 2285357*
- Pulsatile release of valsartan
Novartis 2285358*
- Solid pharmaceutical formulation with delayed release
Bayer Animal Health 2285359*
- Medicament delivery device having an electronic circuit system
Intelliject 2285360*
- Therapeutic calcium phosphate particles and methods of making and using same
Nod Pharmaceuticals 2285361*
- Compsn for transdermal delivery of cationic active agents
LTS Lohmann Therapie-Systeme 2285362*
- Alpha adrenergic receptor agonists for treatment of inflammatory diseases
Warsaw Orthopaedic; Medtronic 2285363*
- Therapeutic replenishment and enrichment of ocular surface lubrication
The Regents of the University of California; Schepens Eye Research Institute 2285364*
- Use of a compsn comprising at least one beta-blocker for the treatment of sleep disorders
Tullin, Soren; Oslen, Birger Jan 2285365*
- Molecules inhibiting a metabolic pathway involving the SYK protein tyrosine kinase and method for identifying said molecules
Centre National de la Recherche Scientifique 2285366*
- Pharmaceutical compsn for the treatment of warts
ATP Marketing & Promotion 2285367*
- New use
Syntopix Group 2285368*
- Sulphobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases
Titian Pharma 2285369*
- Use of a combination of udenafil and alfuzosin or oxybutynon for the treatment of overactive bladder
Plevipharm 2285370*
- Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds
Hoyle, Peter 2285371*
- Selective subtype alpha 2 adrenergic agents and methods for use thereof
Allergan 2285372*
- Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
Cenomed Biosciences 2285373*
- Combination compsns for treating Alzheimer’s disease and related disorders with zonisamide and acamprosate
Pharnext 2285374*
- Spirazaindoles
Merck Sharp & Dohme 2285375*
- 6-aminonicotinamide derivatives as potent and selective histone deacetylase inhibitors
Chipscreen Biosciences 2285376*
- Method for treating cognitive deficits
H Lundbeck 2285377*
- Treatment for ocular-related disorders
Sanofi-Aventis 2285378*
- 1-methylnicotinamide analogues
Cortia 2285379*
- Methods for using TGF-B receptor inhibitors or activin-like kinase (ALK) 5 inhibitors A-83-01 and SB-431542 to treat eye disease and wound healing conditions
Summa Health Systems 2285380*
- Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same
The General Hospital Corp 2285381*
- Steroidal compounds as melanogenesis modifiers and uses thereof
New York University 2285382*